|
Consolidated Statements of Operations and Comprehensive Loss (USD $)
In Thousands, except Share data, unless otherwise specified |
12 Months Ended | |
|---|---|---|
|
Dec. 31, 2014
|
Dec. 31, 2013
|
|
| Statement Of Income And Comprehensive Income [Abstract] | ||
| Product revenue | $ 22,765us-gaap_SalesRevenueNet | $ 22,314us-gaap_SalesRevenueNet |
| Costs of revenue | 7,910us-gaap_CostOfRevenue | 7,045us-gaap_CostOfRevenue |
| Gross profit | 14,855us-gaap_GrossProfit | 15,269us-gaap_GrossProfit |
| Operating expenses: | ||
| Research and development | 6,742us-gaap_ResearchAndDevelopmentExpense | 3,461us-gaap_ResearchAndDevelopmentExpense |
| General and administrative | 13,588us-gaap_GeneralAndAdministrativeExpense | 5,759us-gaap_GeneralAndAdministrativeExpense |
| Sales and marketing | 18,692us-gaap_SellingAndMarketingExpense | 16,384us-gaap_SellingAndMarketingExpense |
| Total operating expenses | 39,022us-gaap_OperatingExpenses | 25,604us-gaap_OperatingExpenses |
| Loss from operations | (24,167)us-gaap_OperatingIncomeLoss | (10,335)us-gaap_OperatingIncomeLoss |
| Other income (expense): | ||
| Interest income | 12us-gaap_InvestmentIncomeInterest | 16us-gaap_InvestmentIncomeInterest |
| Interest expense | (3,650)us-gaap_InterestExpense | (1,851)us-gaap_InterestExpense |
| Loss on extinguishment of debt | (2,194)us-gaap_GainsLossesOnExtinguishmentOfDebt | |
| Change in fair value of derivative liabilities | (251)us-gaap_DerivativeGainLossOnDerivativeNet | 3,970us-gaap_DerivativeGainLossOnDerivativeNet |
| Offering costs | (2,026)amda_OfferingCost | |
| Other expense | (306)us-gaap_OtherNonoperatingIncomeExpense | (86)us-gaap_OtherNonoperatingIncomeExpense |
| Total other income (expense) | (8,415)us-gaap_NonoperatingIncomeExpense | 2,049us-gaap_NonoperatingIncomeExpense |
| Net loss before income taxes | (32,582)us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments | (8,286)us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments |
| Net Loss | (32,582)us-gaap_NetIncomeLoss | (8,286)us-gaap_NetIncomeLoss |
| Other comprehensive loss, net of tax: | ||
| Unrealized loss on marketable securities | (2)us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax | |
| Total comprehensive loss | $ (32,582)us-gaap_ComprehensiveIncomeNetOfTax | $ (8,288)us-gaap_ComprehensiveIncomeNetOfTax |
| Net loss per share attributable to common stockholders: | ||
| Basic and diluted | $ (2.66)us-gaap_EarningsPerShareBasicAndDiluted | $ (15.52)us-gaap_EarningsPerShareBasicAndDiluted |
| Weighted average common shares outstanding: | ||
| Basic and diluted | 12,239,953us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted | 534,073us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted |
| X | ||||||||||
|
- Definition
Expensed offering costs with unit offering. No definition available.
|
| X | ||||||||||
|
- Definition
Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
The aggregate cost of goods produced and sold and services rendered during the reporting period. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Amount of increase (decrease) in the fair value of derivatives recognized in the income statement. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Details
|
| X | ||||||||||
|
- Definition
The amount of net income or loss for the period per each share in instances when basic and diluted earnings per share are the same amount and reported as a single line item on the face of the financial statements. Basic earnings per share is the amount of net income or loss for the period per each share of common stock or unit outstanding during the reporting period. Diluted earnings per share includes the amount of net income or loss for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period. No definition available.
|
| X | ||||||||||
|
- Definition
Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Sum of operating profit and nonoperating income or expense before Income or Loss from equity method investments, income taxes, extraordinary items, and noncontrolling interest. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Amount of the cost of borrowed funds accounted for as interest expense. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Amount before accretion (amortization) of purchase discount (premium) of interest income on nonoperating securities. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business). Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Details
|
| X | ||||||||||
|
- Definition
Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense. No definition available.
|
| X | ||||||||||
|
- Details
|
| X | ||||||||||
|
- Definition
The net result for the period of deducting operating expenses from operating revenues. No definition available.
|
| X | ||||||||||
|
- Details
|
| X | ||||||||||
|
- Definition
Amount after tax, before reclassification adjustments, of unrealized holding gain (loss) on available-for-sale securities. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
The net amount of other income and expense amounts, the components of which are not separately disclosed on the income statement, resulting from ancillary business-related activities (that is, excluding major activities considered part of the normal operations of the business) also known as other nonoperating income (expense) recognized for the period. Such amounts may include: (a) dividends, (b) interest on securities, (c) net gains or losses on securities, (d) unusual costs, (e) gains or losses on foreign exchange transactions, and (f) miscellaneous other income and expense items. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Total revenue from sale of goods and services rendered during the reporting period, in the normal course of business, reduced by sales returns and allowances, and sales discounts. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
The aggregate total amount of expenses directly related to the marketing or selling of products or services. No definition available.
|
| X | ||||||||||
|
- Details
|
| X | ||||||||||
|
- Definition
Average number of shares or units issued and outstanding that are used in calculating basic and diluted earnings per share (EPS). No definition available.
|
| X | ||||||||||
|
- Details
|